LIOTRIX (T4;T3) - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for liotrix (t4;t3) and what is the scope of patent protection?
Liotrix (t4;t3)
is the generic ingredient in ten branded drugs marketed by Parke Davis and Allergan, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for LIOTRIX (T4;T3)
| US Patents: | 0 |
| Tradenames: | 10 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| Patent Applications: | 896 |
| DailyMed Link: | LIOTRIX (T4;T3) at DailyMed |
US Patents and Regulatory Information for LIOTRIX (T4;T3)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | THYROLAR-1 | liotrix (t4;t3) | TABLET;ORAL | 016807-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan | THYROLAR-5 | liotrix (t4;t3) | TABLET;ORAL | 016807-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | EUTHROID-2 | liotrix (t4;t3) | TABLET;ORAL | 016680-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan | THYROLAR-0.25 | liotrix (t4;t3) | TABLET;ORAL | 016807-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan | THYROLAR-3 | liotrix (t4;t3) | TABLET;ORAL | 016807-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan | THYROLAR-0.5 | liotrix (t4;t3) | TABLET;ORAL | 016807-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | EUTHROID-1 | liotrix (t4;t3) | TABLET;ORAL | 016680-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
